"Our core mission is to improve people's lives through revolutionary new healthcare treatments," said
The protective microencapsulation system is named Microvail™ and it creates microcapsules that protect protein and peptide-based drugs and micronutrients from being damaged by stomach acids and enzymatic degradation, including the peptide hormone, insulin.
"The Microvail™ technology addresses another big challenge, namely that many of the most promising micronutrients are poorly bioavailable. By using this Microvail™ technology, a higher percentage of nutrients is delivered into the bloodstream, thus revolutionizing the vitamin and supplement industries," continued
Response Scientific will use the Microvail™ technology to manufacture Microvail™ micronutrients (nutraceuticals) bringing a new level of bioavailability to the market. Webster said, "The Microvail™ nutraceutical strategy not only solves the absorption problem in the vitamin and supplement market, but also allows Response Scientific to move faster into the market."
Response Scientific is closing new investment rounds to support 2014 production and marketing development. The Microvail™ products will launch in the Canadian market this year and will utilize some of the new investment for marketing and distribution.
"We are very excited to bring Microvail™ to market this year," said
About Response Scientific
Response Scientific is an innovative research company at the forefront of developing revolutionary new healthcare treatments. Response Scientific is the developer of the breakthrough Microvail™ products, highly bioavailable microencapsulated micronutrients proven to deliver more contents into the bloodstream. They are also the developer of Receptorex™, a patented medical food candidate that lowers the amount of insulin required to maintain healthy glucose levels. Response Scientific is located in
CONTACT: Media Contact:
Heather Bledsoe Hitman, Inc.| (212) 300.6026